1. Home
  2. LDI vs DBVT Comparison

LDI vs DBVT Comparison

Compare LDI & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo loanDepot Inc.

LDI

loanDepot Inc.

HOLD

Current Price

$2.10

Market Cap

954.8M

Sector

Finance

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$19.08

Market Cap

769.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LDI
DBVT
Founded
2010
2002
Country
United States
France
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
954.8M
769.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
LDI
DBVT
Price
$2.10
$19.08
Analyst Decision
Sell
Buy
Analyst Count
3
7
Target Price
$3.00
$31.75
AVG Volume (30 Days)
3.8M
709.3K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,095,780,000.00
$5,502,000.00
Revenue This Year
$24.99
$1,768.71
Revenue Next Year
$18.02
$1,028.88
P/E Ratio
N/A
N/A
Revenue Growth
10.74
N/A
52 Week Low
$1.01
$2.99
52 Week High
$5.05
$26.19

Technical Indicators

Market Signals
Indicator
LDI
DBVT
Relative Strength Index (RSI) 35.90 55.95
Support Level $2.02 $18.78
Resistance Level $2.88 $19.90
Average True Range (ATR) 0.12 1.39
MACD -0.02 -0.23
Stochastic Oscillator 11.18 18.19

Price Performance

Historical Comparison
LDI
DBVT

About LDI loanDepot Inc.

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: